This may be explained, at least partially, by the finding of frequent MYC point mutations in DLBCL cases with a MYC/IG gene translocation (~65%), compared with cases harboring a MYC/non-IG rearrangement (~13%) [4]. Here, MYC is linked to diffuse large B-cell lymphoma.